MEDS:NSD-Trxade Group Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 7.31

Change

+0.02 (+0.27)%

Market Cap

USD 0.01B

Volume

0.01M

Analyst Target

USD 11.25
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
WBA Walgreens Boots Alliance Inc

N/A

USD 7.82B
HITI High Tide Inc

-0.02 (-0.90%)

USD 0.16B
PETS PetMed Express Inc

+0.19 (+5.14%)

USD 0.08B
CJJD China Jo-Jo Drugstores Inc

-0.36 (-12.86%)

USD 0.01B
LFLYW Leafly Holdings Inc

N/A

N/A
MDVLQ MedAvail Holdings Inc

N/A

N/A

ETFs Containing MEDS

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 40.69% 83% B 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.69% 83% B 88% B+
Trailing 12 Months  
Capital Gain 9.76% 83% B 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.76% 83% B 52% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -19.35% N/A N/A 17% F
Dividend Return -19.35% N/A N/A 17% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 129.38% N/A N/A 14% F
Risk Adjusted Return -14.96% N/A N/A 30% F
Market Capitalization 0.01B 40% F 14% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector